Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SAU:4013's EV-to-EBIT is ranked worse than 78.29% of 479
companies
in the Healthcare Providers & Services industry
Industry Median: 15.14
vs SAU:4013: 30.14
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Dr Sulaiman Al Habib Medical Services Group's Enterprise Value for the quarter that ended in Jun. 2026 was ﷼82,130 Mil.
Dr Sulaiman Al Habib Medical Services Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼2,965 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group EV-to-EBIT Related Terms
Dr Sulaiman Al Habib Medical Services Group EV-to-EBIT Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group EV-to-EBIT Chart
Dr Sulaiman Al Habib Medical Services Group Annual Data
For the Medical Care Facilities subindustry, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dr Sulaiman Al Habib Medical Services Group EV-to-EBIT vs Healthcare Providers & Services Industry
Dr Sulaiman Al Habib Medical Services Group's current Enterprise Value is ﷼89,375 Mil.
Dr Sulaiman Al Habib Medical Services Group's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ﷼2,965 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dr Sulaiman Al Habib Medical Services Group (SAU:4013) has a EV-to-EBIT of 30.14 as of Sep. 11, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. This is 26% below median its historical median of 40.79. Over the past decade, Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT has ranged from 21.27 to 55.79. According to the industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #375 out of 479 companies in the Healthcare Providers & Services industry, placing it in the top 78.3%.
Is Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT too high?
Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBIT of 30.14 is 26% below median its 10-year median of 40.79. Over the past 10 years, this metric has ranged from a low of 21.27 to a high of 55.79. The Healthcare Providers & Services industry median EV-to-EBIT is 15.14. Dr Sulaiman Al Habib Medical Services Group's value of 30.14 is 99.1% above this industry median. Based on the distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #375 out of 479 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Dr Sulaiman Al Habib Medical Services Group has a GF Score™ of 96/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Dr Sulaiman Al Habib Medical Services Group's EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Dr Sulaiman Al Habib Medical Services Group ranks #375 out of 479 companies for EV-to-EBIT. This places Dr Sulaiman Al Habib Medical Services Group in the lower half of its industry. The industry median EV-to-EBIT is 15.14. Dr Sulaiman Al Habib Medical Services Group's value of 30.14 is 99.1% above this benchmark. Historically, Dr Sulaiman Al Habib Medical Services Group's own EV-to-EBIT has ranged from 21.27 to 55.79 over the past decade. While the company's 10-year median is 40.79 vs. the industry median of 15.14, Dr Sulaiman Al Habib Medical Services Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.14, based on 479 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBIT of 30.14 is 99.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Dr Sulaiman Al Habib Medical Services Group and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dr Sulaiman Al Habib Medical Services Group's current EV-to-EBIT is 30.14, which is 26% below median its own 10-year median of 40.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dr Sulaiman Al Habib Medical Services Group stock overvalued right now?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group (SAU:4013) is currently considered Significantly Undervalued. The stock's GF Value™ is ﷼380.38, compared to a current price of ﷼232.70 — trading 38.8% below its estimated fair value. The current EV-to-EBIT is 30.14, which is 26% below median its 10-year median of 40.79 and 99.1% above the Healthcare Providers & Services industry median of 15.14. Dr Sulaiman Al Habib Medical Services Group's overall GF Score™ is 96/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Dr Sulaiman Al Habib Medical Services Group (SAU:4013), the current EV-to-EBIT is 30.14 as of Sep. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dr Sulaiman Al Habib Medical Services Group (SAU:4013) Overvalued in 2026?
Based on GuruFocus' analysis, Dr Sulaiman Al Habib Medical Services Group stock appears to be undervalued.
The current stock price of ﷼232.70 is trading 38.8% below its estimated GF Value™ of ﷼380.38.
GuruFocus considers Dr Sulaiman Al Habib Medical Services Group to be Significantly Undervalued.
Key valuation signals for SAU:4013:
EV-to-EBIT: 30.14 (26% below median its 10-year median of 40.79)
GF Value™: ﷼380.38 vs. price of ﷼232.70 (38.8% below fair value)
Industry Position: 99.1% above the Healthcare Providers & Services median (#375 of 479)
No single metric tells the full story. See the SAU:4013 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dr Sulaiman Al Habib Medical Services Group provides private health and ancillary services in the Kingdom and the region through the establishment, management, and operation of hospitals, medical complexes, day surgery centers, pharmaceutical facilities, and other ancillary areas, including home health care, specialized laboratories, technology and information systems, facility maintenance, tele-medicine, revenue cycle management, medical equipment maintenance, and real estate activity. The company reports in three segments: Hospitals and Healthcare Facilities, Pharmacies, and HMG Solutions and Others. The majority of revenue comes from the Hospitals and Healthcare Facilities segment.
96GF Score
Get the complete analysis for SAU:4013
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SAU:4013 has been successfully added to your 
